Yo, check this out: there’s some big news in the pharmaceutical game. Saama, these AI wizards who are all about accelerating clinical development, just hooked up with one of the heavy hitters, AstraZeneca. They struck a multi-year agreement to revolutionize AstraZeneca’s clinical data management and medical review processes using Saama’s kickass AI-enabled technology platform. And they’re not just trying to level up the game, they’re aiming to set a new standard for how clinical development is done!
According to Lisa Moneymaker, Saama’s Chief Technology Officer and Chief Product Officer, this move is all about recognizing the need for a serious change in drug development. The vision here is to bring treatments to patients faster by leveraging the power of AI. And AstraZeneca is completely on board with this mission. They’re integrating Saama’s platform into their data management and review systems, taking advantage of Saama’s Smart Data Quality, Data Hub, and Patient Insights solutions. The goal? Faster clinical database lock, more efficient data reviews, and smarter medical review processes.
Natalie Fishburn, Vice President and Head of Clinical Operations BioPharmaceuticals R&D at AstraZeneca, is all about leveraging cutting-edge tech to modernize their processes. She’s hyped about Saama’s platform because it complements their own efforts to automate tasks, simplify data flows, and tap into the power of AI for killer insights. And believe me, when it comes to clinical trials, proper data review is crucial for making sure the results are legit.
Crazy thing is, Saama’s platform isn’t just any old software. Their Smart Data Quality, Data Hub, and Patient Insights solutions are top of the line, using the most advanced technology and AI capabilities. They’re designed to handle the massive amount and variety of data that comes with today’s clinical trials. Basically, they centralize and standardize data from different sources to make medical review processes smoother, improve patient safety oversight, predict participant behavior, and even speed up the discovery of clinical signals.
If you’re curious about this game-changing platform, check out saama.com. They’ve got a whole range of AI-powered SaaS solutions that cover every step of the clinical development process. You wanna see it in action? Schedule a personalized demo. These folks are serious about saving and improving lives, and they’ve got the technology to back it up.
And that’s the scoop, folks! Stay tuned for more news and updates.
Saama is out here changing the game in life sciences. These guys are all about accelerating the delivery of therapies to patients. They’ve got some mind-blowing AI tech that brings breakthrough intelligence into clinical and commercial operations. And get this, their platform powered the clinical trial that led to the world’s first COVID-19 vaccine. Based in Campbell, CA, but with a global reach, Saama is on a mission to save and improve lives. Look ’em up at saama.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20231017498809/en/